[Ningbo Central and Eastern European Pharmaceutical Trading (Centralized Purchasing) Platform Officially Launched] On September 22, reporters learned that the Ningbo Central and Eastern European Pharmaceutical Trading (Centralized Purchasing) Platform was officially launched today. The platform is the fourth international pharmaceutical and device trading platform built under the guidance of the National Medical Insurance Administration. It relies on the foundation of economic and trade cooperation between Ningbo and Central and Eastern European countries and the professional advantages of medical insurance procurement to provide cross-border transactions and other professional services for the overseas development of domestic pharmaceutical companies. According to reports, the trading platform mainly includes four core functions: "product window display, docking between supply and demand parties, comprehensive foreign trade services, and data display boards", realizing online and offline interoperability, classified partition management, and settlement services. As of mid-September, nearly 500 supply companies and more than 20 overseas buyers have settled on the platform, with more than 4,000 products on the shelves, covering six categories: APIs, preparations, traditional Chinese medicine pieces, medical consumables, diagnostic reagents and medical equipment. During the trial operation, the order transaction amount exceeded 200 million yuan, and the export area covers major European and American countries and emerging markets. Leading companies in various categories such as Hengrui Pharmaceuticals, Qilu Pharmaceuticals, Hisun Pharmaceuticals, and David Medical have already settled in. (Reporters Lu Afeng and Yu Miao)